Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2017 (2017), Article ID 4104137, 8 pages
https://doi.org/10.1155/2017/4104137
Research Article

Interleukin-1 Receptor Antagonist and Interleukin-4 Genes Variable Number Tandem Repeats Are Associated with Adiposity in Malaysian Subjects

Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman (UTAR), Kampar Campus, Jalan Universiti, Bandar Barat, 31900 Kampar, Perak, Malaysia

Correspondence should be addressed to Yee-How Say; ym.ude.ratu@hyyas

Received 5 August 2016; Accepted 17 January 2017; Published 15 February 2017

Academic Editor: Aron Weller

Copyright © 2017 Yung-Yean Kok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ng, T. Fleming, M. Robinson et al., “Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 384, no. 9945, pp. 766–781, 2014. View at Publisher · View at Google Scholar
  2. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Shu, C. Benoist, and D. Mathis, “The immune system's involvement in obesity-driven type 2 diabetes,” Seminars in Immunology, vol. 24, no. 6, pp. 436–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Perrier, F. Darakhshan, and E. Hajduch, “IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?” FEBS Letters, vol. 580, no. 27, pp. 6289–6294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. E. Juge-Aubry, E. Somm, V. Giusti et al., “Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation,” Diabetes, vol. 52, no. 5, pp. 1104–1110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Somm, E. Henrichot, A. Pernin et al., “Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure,” Diabetes, vol. 54, no. 12, pp. 3503–3509, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Meier, E. Bobbioni, C. Gabay, F. Assimacopoulos-Jeannet, A. Golay, and J.-M. Dayer, “IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 1184–1188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Vamvakopoulos, C. J. Taylor, G. J. Morris-Stiff, C. Green, and S. Metcalfe, “The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism,” European Journal of Immunogenetics, vol. 29, no. 4, pp. 337–340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. K. Tarlow, A. I. F. Blakemore, A. Lennard et al., “Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat,” Human Genetics, vol. 91, no. 4, pp. 403–404, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Witkin, S. Gerber, and W. J. Ledger, “Influence of interleukin-1 receptor antagonist gene polymorphism on disease,” Clinical Infectious Diseases, vol. 34, no. 2, pp. 204–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Nelms, A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul, “The IL-4 receptor: signaling mechanisms and biologic functions,” Annual Review of Immunology, vol. 17, pp. 701–738, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Mito, T. Hosoda, C. Kato, and K. Sato, “Change of cytokine balance in diet-induced obese mice,” Metabolism: Clinical and Experimental, vol. 49, no. 10, pp. 1295–1300, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. E. Borst, C. F. Conover, and G. J. Bagby, “Association of resistin with visceral fat and muscle insulin resistance,” Cytokine, vol. 32, no. 1, pp. 39–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-H. Chang, K.-T. Ho, S.-H. Lu, C.-N. Huang, and M.-Y. Shiau, “Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4,” International Journal of Obesity, vol. 36, no. 7, pp. 993–998, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Mout, R. Willemze, and J. E. Landegent, “Repeat polymorphisms in the interleukin-4 gene (IL4),” Nucleic Acids Research, vol. 19, no. 13, p. 3763, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Olsson, “Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis,” Neurology, vol. 45, pp. S11–S15, 1995. View at Google Scholar
  17. N. Buchs, T. Silvestri, F. S. di Giovine et al., “IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction,” Rheumatology, vol. 39, no. 10, pp. 1126–1131, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M.-C. Wu, C.-M. Huang, J. J. P. Tsai, H.-Y. Chen, and F.-J. Tsai, “Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan,” Lupus, vol. 12, no. 1, pp. 21–25, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Sobti, N. Maithil, H. Thakur, Y. Sharma, and K. K. Talwar, “VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population,” Molecular and Cellular Biochemistry, vol. 341, no. 1-2, pp. 139–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Tekcan, S. Yigit, A. Rustemoglu, C. Gurel, S. Sahin, and T. Tasliyurt, “The investigation of obesity susceptibility with IL-4 gene intron 3 VNTR and IL-6 gene -597G/A polymorphisms in a turkish population,” International Journal of Human Genetics, vol. 13, no. 4, pp. 209–213, 2013. View at Google Scholar · View at Scopus
  21. S.-K. Yiew, L.-Y. Khor, M.-L. Tan et al., “No association between peroxisome proliferator-activated receptor and uncoupling protein gene polymorphisms and obesity in Malaysian university students,” Obesity Research and Clinical Practice, vol. 4, no. 4, pp. e325–e331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. M. Chan, S. H. Fan, and Y. H. Say, “No association of Peptide Tyrosine-Tyrosine (PYY) gene R72t variant with obesity in the Kampar Health Clinic Cohort, Malaysia,” Malaysian Journal of Nutrition, vol. 17, no. 2, pp. 201–212, 2011. View at Google Scholar · View at Scopus
  23. WHO/IOTF/IASO, The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, World Health Organization, International Obesity Task Force, International Association for the Study of Obesity, Hong Kong, 2000.
  24. Omron, Omron KARADA Scan Body Composition & Scale (HBF-362), Omron Healthcare, Muko, Japan, 2007.
  25. WHO, Waist Circumference and Waist-hip Ratio: Report of a WHO Expert Consultation, WHO Press, Geneva, Switzerland, 2011.
  26. M. Aidar and S. R. P. Line, “A simple and cost-effective protocol for DNA isolation from buccal epithelial cells,” Brazilian Dental Journal, vol. 18, no. 2, pp. 148–152, 2007. View at Google Scholar · View at Scopus
  27. P. K. Manchanda, H. K. Bid, and R. D. Mittal, “Ethnicity greatly influences the interleukin-1 gene cluster(IL-1ββ promoter, exon-5 and IL-1Ra) polymorphisms: a pilot study of a north Indian population,” Asian Pacific journal of cancer prevention: APJCP, vol. 6, no. 4, pp. 541–546, 2005. View at Google Scholar · View at Scopus
  28. J. Jiang, X. Zhang, D. Sun et al., “Study on VNTR polymorphism of gene IL-1RA in 19 Chinese populations,” International Journal of Immunogenetics, vol. 37, no. 2, pp. 73–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. G. Parks, G. S. Cooper, M. A. Dooley et al., “Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States,” Annals of the Rheumatic Diseases, vol. 63, no. 1, pp. 91–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Vandenbroeck, G. Martino, M. G. Marrosu et al., “Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis,” Journal of Neuroimmunology, vol. 76, no. 1-2, pp. 189–192, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Huang, S. Xia, Y. Zhou, R. Pirskanen, L. Liu, and A. K. Lefvert, “No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis,” Journal of Neuroimmunology, vol. 92, no. 1-2, pp. 208–211, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Cantagrel, F. Navaux, P. Loubet-Lescoulié et al., “Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 42, no. 6, pp. 1093–1100, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Nakashima, K. Miyake, Y. Inoue et al., “Association between IL-4 genotype and IL-4 production in the Japanese population,” Genes and Immunity, vol. 3, pp. 107–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Vasudevan, M. N. Norhasniza, and I. Patimah, “Association of variable number of tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in Malaysian patients,” Genetics and Molecular Research, vol. 10, no. 2, pp. 943–947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Hurme and S. Santtila, “IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes,” European Journal of Immunology, vol. 28, no. 8, pp. 2598–2602, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-Y. Um, H.-M. Kim, S.-W. Mun, Y.-S. Song, and S.-H. Hong, “Interleukin-1 receptor antagonist gene polymorphism and traditional classification in obese women,” International Journal of Neuroscience, vol. 116, no. 1, pp. 39–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. P. K. Manchanda, H. K. Bid, B. R. Achyut, B. Mittal, N. Srivastava, and R. D. Mittal, “Interleukin-1 receptor antagonist gene polymorphism and obesity: A Pilot Study from North India,” Indian Journal of Clinical Biochemistry, vol. 22, no. 1, pp. 61–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Deurenberg-Yap, G. Schmidt, W. A. Van Staveren, and P. Deurenberg, “The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore,” International Journal of Obesity, vol. 24, no. 8, pp. 1011–1017, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hurme and M. Helminen, “Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes,” Scandinavian Journal of Infectious Diseases, vol. 30, no. 5, pp. 447–449, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Mustea, J. Sehouli, D. Könsgen, D. Stengel, D. Sofroni, and W. Lichtenegger, “Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer,” Anticancer Research, vol. 23, no. 2A, pp. 1099–1102, 2003. View at Google Scholar · View at Scopus
  41. O. Mwantembe, M.-C. Gaillard, M. Barkhuizen et al., “Ethnic differences in allelic associations of the interleukin-1 gene cluster in south african patients with inflammatory bowel disease (IBD) and in control individuals,” Immunogenetics, vol. 52, no. 3-4, pp. 249–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Salimi, M. Mohammadoo-Khorasani, M. Yaghmaei, M. Mokhtari, and M. Moossavi, “Possible association of IL-4 VNTR polymorphism with susceptibility to preeclampsia,” BioMed Research International, vol. 2014, Article ID 497031, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Inanir, S. Tural, S. Yigit et al., “Association of IL-4 gene VNTR variant with deep venous thrombosis in Behçet's disease and its effect on ocular involvement,” Molecular Vision, vol. 19, pp. 675–683, 2013. View at Google Scholar · View at Scopus
  44. C.-H. Tsao, M.-Y. Shiau, P.-H. Chuang, Y.-H. Chang, and J. Hwang, “Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis,” Journal of Lipid Research, vol. 55, pp. 385–397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. R. R. Rao, J. Z. Long, J. P. White et al., “Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis,” Cell, vol. 157, no. 6, pp. 1279–1291, 2014. View at Publisher · View at Google Scholar · View at Scopus